Latest News about ABBV
Recent news which mentions ABBV
Meet the Next Trillion-Dollar Companies: Our Top 3 Picks
November 02, 2023
From InvestorPlace
EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience'
November 02, 2023
From Benzinga
3 Dividend Stocks That Are Investor Safe Havens
November 02, 2023
From InvestorPlace
3 Dividend Stocks That Can Power Your Portfolio for Decades
November 02, 2023
From Motley Fool
Why Is Aldeyra Therapeutics (ALDX) Stock Up 40% Today?
November 01, 2023
From InvestorPlace
Pfizer Posted a Steep Loss. Is It Time to Sell?
November 01, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 31, 2023
From Benzinga
From MarketWatch
From Motley Fool
Amgen Lifts Annual Outlook After Q3 Performance, But Stock Still Falls - Here's Why
October 31, 2023
From Benzinga
Why AbbVie Stock Was a Winner on Monday
October 30, 2023
From Motley Fool
AbbVie Analysts Increase Their Forecasts After Upbeat Earnings
October 30, 2023
Tickers
ABBV
From Benzinga
2 No-Brainer Dividend Stocks to Buy This Week
October 30, 2023
From Motley Fool
From Benzinga
FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie
October 27, 2023
From Benzinga
AbbVie Raises Annual Profit Outlook As Newer Immunology Drugs Help Cushion Struggling Humira Sales
October 27, 2023
Tickers
ABBV
From Benzinga
AbbVie results beat expectations despite low-cost competition to blockbuster Humira
October 27, 2023
From MarketWatch
Earnings Scheduled For October 27, 2023
October 27, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.